China Biologic Products, Inc. (CBPO)

[surf1944]

8:01AM China Biologic products subsidiary awarded center of excellence designation in China (CBPO) 10.99 : Co announced that its indirect majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd. ("Shandong Taibang"), has been recognized as one of Shandong's National Centers of Excellence for New Drug and Technology Development ("SNC") by the Department of Science and Technology of Shandong Province (the "DSTSP"). The DSTSP created the SNC designation to help implement and advance major drug development strategies proposed by China's Ministry of Science and Technology of PRC. SNC companies are chosen based on a number of criterion including: annual sales exceeding 500 mln RMB (or ~$73 mln) or ownership of independent intellectual property rights for new drugs; Good Manufacturing Practices (GMP) certified; a track record of strong pharmaceutical R&D capabilities and highly qualified R&D team; and evidence of continued commitment to and advances in new drug development.